Literature DB >> 29116626

Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance.

Kumi Ozaki1, Kenichi Harada2, Toru Yamamoto3, Hiroyuki Aoyagi4, Yasuharu Kaizaki5, Jun Yoshikawa3.   

Abstract

The patient was a 43-year-old woman with obesity (body mass index: 29.1) and glucose intolerance who was not taking oral contraceptives. An ultrasound showed a hypoechoic hepatic mass. Dynamic contrast-enhanced computed tomography revealed a lesion in segment 6 that showed homogeneous and slight-to-moderate enhancement in the arterial phase with persistent enhancement during the portal and equilibrium phases. On magnetic resonance (MR) imaging, the lesion demonstrated hyperintensity on T2- and diffusion-weighted images and hypointensity in the hepatobiliary phase of gadoxetic-acid-enhanced MR imaging. In addition to the main lesion, approximately ten small hypointense lesions were seen in the hepatobiliary phase. The background liver was fatty without the deformity of chronic liver disease. Based on the pathological findings of the main lesion biopsy, it was initially suspected to be a non-neoplastic lesion with hematoxylin and eosin staining and initial immunohistochemical staining. However, the radiological findings indicated a neoplastic lesion. Additional immunohistochemical staining, including that for α-smooth muscle actin and organic anion transporter polypeptide 1B3, in combination with the radiological findings resulted in a diagnosis of unclassified hepatocellular adenoma. The other small lesions were presumed to be related to the main lesion.

Entities:  

Keywords:  Diabetes mellitus; Gadoxetic acid; Glucose intolerance; Organic anion transporter polypeptide 1B3; Unclassified hepatocellular adenoma

Mesh:

Substances:

Year:  2017        PMID: 29116626     DOI: 10.1007/s12328-017-0788-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  16 in total

1.  Hepatic adenomatosis in a young woman with glucose intolerance.

Authors:  Kiran Bambha; David Nagorney; Schuyler Sanderson; Gregory J Gores
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-09

2.  Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin.

Authors:  Toshio Fukusato; Yurie Soejima; Fukuo Kondo; Masafumi Inoue; Masato Watanabe; Yoshihisa Takahashi; Tatsuya Aso; Hiroshi Uozaki; Keiji Sano; Yukihiro Sanada; Toshiro Niki
Journal:  Hepatol Res       Date:  2014-12-24       Impact factor: 4.288

3.  Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images.

Authors:  Norihide Yoneda; Osamu Matsui; Azusa Kitao; Ryuuichi Kita; Kazuto Kozaka; Wataru Koda; Satoshi Kobayashi; Toshifumi Gabata; Hiroko Ikeda; Yasunori Sato; Yasuni Nakanuma
Journal:  Jpn J Radiol       Date:  2012-05-24       Impact factor: 2.374

4.  Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification.

Authors:  Susanna M van Aalten; Maarten G J Thomeer; Türkan Terkivatan; Roy S Dwarkasing; Joanne Verheij; Robert A de Man; Jan N M Ijzermans
Journal:  Radiology       Date:  2011-08-26       Impact factor: 11.105

Review 5.  Genetics and imaging of hepatocellular adenomas: 2011 update.

Authors:  Venkata S Katabathina; Christine O Menias; Alampady K P Shanbhogue; Jaishree Jagirdar; Raj Mohan Paspulati; Srinivasa R Prasad
Journal:  Radiographics       Date:  2011-10       Impact factor: 5.333

6.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

7.  Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8.

Authors:  Norihide Yoneda; Osamu Matsui; Azusa Kitao; Kazuto Kozaka; Toshifumi Gabata; Motoko Sasaki; Yasuni Nakanuma; Kiyoshi Murata; Toru Tani
Journal:  Jpn J Radiol       Date:  2012-08-23       Impact factor: 2.374

8.  Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.

Authors:  Stephen M Lagana; Marcela Salomao; Fei Bao; Roger K Moreira; Jay H Lefkowitch; Helen E Remotti
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-03

9.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

10.  Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.

Authors:  Justin R Tse; Bita V Naini; David S K Lu; Steven S Raman
Journal:  Radiology       Date:  2015-10-27       Impact factor: 11.105

View more
  1 in total

1.  ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice.

Authors:  Margaux Sala; Delphine Gonzales; Thierry Leste-Lasserre; Nathalie Dugot-Senant; Valérie Paradis; Sylvaine Di Tommaso; Jean-William Dupuy; Vincent Pitard; Cyril Dourthe; Amedeo Sciarra; Christine Sempoux; Linda D Ferrell; Andrew D Clouston; Gregory Miller; Mathew M Yeh; Swan Thung; Annette S H Gouw; Alberto Quaglia; Jing Han; Ji Huan; Cathy Fan; James Crawford; Yasuni Nakanuma; Kenichi Harada; Brigitte le Bail; Claire Castain; Nora Frulio; Hervé Trillaud; Laurent Possenti; Jean-Frédéric Blanc; Laurence Chiche; Christophe Laurent; Charles Balabaud; Paulette Bioulac-Sage; Anne Aurélie Raymond; Frédéric Saltel
Journal:  Hepatol Commun       Date:  2020-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.